High impact information on NDUFB8

• HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III [1].
• A total of 88 quality control samples of various ethnic groups distributed in the International Cell Exchange and HLA DNA Exchange programs and the ASHI/CAP Proficiency Tests were investigated by the PCR-RFLP/SSCP method [2].
• Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists [3].
• Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching. American Society for Histocompatibility of Immunogenetics. College of American Pathologists [4].
• Automation of the fluorescent method required a calculation that converts electronic data to an ASHI score for cell death [5].

Analytical, diagnostic and therapeutic context of NDUFB8

• The Histocompatibility Survey Program was organized in 1982 as a joint project by the ASHI and CAP to evaluate laboratory performance in HLA typing, lymphocytotoxicity crossmatching, and antibody analysis [3].
• Outcome of renal transplantation following a positive cross-match with historical sera: the ASHI survey [6].

References